A carregar...

Safety and efficacy of azacitidine in myelodysplastic syndromes

PURPOSE: The clinical efficacy, different dosages, treatment schedules, and safety of azacitidine are reviewed. SUMMARY: Azacitidine is the first drug FDA-approved for the treatment of myelodysplastic syndromes that has demonstrated improvements in overall survival and delaying time to progression t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vigil, Carlos E, Martin-Santos, Taida, Garcia-Manero, Guillermo
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2948932/
https://ncbi.nlm.nih.gov/pubmed/20957213
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!